MedPath

The Effect of Integrating Psychodrama with Cognitive Behavioral Group Therapy on Fear of Negative Evaluation, Interpersonal Sensitivity and Focused Attention in Female Adolescences with Social Anxiety Disorder

Not Applicable
Conditions
Social Anxiety Disorder.
In this disorder there is a wariness of strangers and social apprehension or anxiety when encountering new, strange, or socially threatening situations. This category should be used only where such fears arise during the early years, and are both unusual
F93.2
Registration Number
IRCT20230228057557N1
Lead Sponsor
Shahid Chamran University of Ahvaz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

Having social anxiety disorder based on the screening score in the research instrument and clinical interview based on DSM-5, expressing willingness and informed consent to participate in the research, adhering to group rules such as confidentiality, respecting other group members and attending group meetings on time. Studying in one of the girls' schools and the absence of concurrent mental disorders such as depression.

Exclusion Criteria

Criteria for dropping out of the study: absence of more than two sessions, dropping out of school, not cooperating with the therapist and other members of the group, receiving any other training or treatment during the research period.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Social anxiety - interpersonal sensitivity - fear of negative evaluation and self-focused attention. Timepoint: Before starting the study, social anxiety-interpersonal sensitivity-focused attention-fear of negative evaluation was evaluated and the intervention was implemented twice a week for 12 sessions and followed up after one month. Method of measurement: 1- Adolescent Social Anxiety Scale (SASA) 2- Short Form of Fear of Negative Evaluation (FNEB) 3- Interpersonal Sensitivity Questionnaire 4- Focus of Attention Scale (FAQ).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath